Evidence map›Paper›PMID 24586678›Full record

ArticlePloS one2014

Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins.

Machi Yanai, Miguel A Rocha, Anthony Z Matolek, Archana Chintalacharuvu, Yasuhiko Taira, Koteswara Chintalacharuvu, David O Beenhouwer

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Molecular Characteristics and Pathogenicity ofInternational journal of molecular sciences · 2023
    Review
  5. Clinical Impact ofAntibiotics (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Exploring the Role ofToxins · 2022
    Review
  9. Article
  10. Microbiology spectrum · 2019
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Machi YanaiDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America ; Emergency and Critical Care, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Miguel A RochaDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.
Anthony Z MatolekDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.
Archana ChintalacharuvuDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.
Yasuhiko TairaEmergency and Critical Care, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Koteswara ChintalacharuvuDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.
David O BeenhouwerDivision of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America ; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
VA Greater Los Angeles Healthcare System · USSt. Marianna University School of Medicine · JPUniversity of California, Los Angeles · US

Funding

Antibody cytokine fusion proteins against Cryptococcus neoformansR01AI071025 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI BEENHOUWER, DAVID OWEN · 2008 to 2012
$1.6M
NIAID NIH HHS AI071025NIAID NIH HHS R01 AI071025
6 · The paper itself

Abstract

Staphylococcus aureus is a major human pathogen that elaborates several exotoxins. Among these are the bicomponent leukotoxins (BCLs), which include γ-hemolysin, Panton-Valentine leukocidin (PVL), and LukDE. The toxin components are classified as either F or S proteins, which are secreted individually and assemble on cell surfaces to form hetero-oligomeric pores resulting in lysis of PMNs and/or erythrocytes. F and S proteins of γ-hemolysin, PVL and LukDE have ∼ 70% sequence homology within the same class and several heterologous combinations of F and S members from these three bicomponent toxin groups are functional. Recently, an additional BCL pair, LukGH (also called LukAB) that has only 30% homology to γ-hemolysin, PVL and LukDE, has been characterized from S. aureus. Our results showed that LukGH was more cytotoxic to human PMNs than PVL. However, LukGH-induced calcium ion influx in PMNs was markedly attenuated and slower than that induced by PVL and other staphylococcal BCLs. In contrast to other heterologous BCL combinations, LukG in combination with heterologous S components, and LukH in combination with heterologous F components did not induce calcium ion entry or cell lysis in human PMNs or rabbit erythrocytes. Like PVL, LukGH induced IL-8 production by PMNs. While individual components LukG and LukH had no cytolytic or calcium influx activity, they each induced high levels of IL-8 transcription and secretion. IL-8 production induced by LukG or LukH was dependent on NF-κB. Therefore, our results indicate LukGH differs functionally from other staphylococcal BCLs.

Indexed as

AnimalsApoptosisBacterial ProteinsBacterial ToxinsBlotting, WesternCalciumCell ProliferationCells, CulturedErythrocytesExotoxinsHemolysin ProteinsHemolysisHumansInterleukin-8LeukocidinsNeutrophilsBacterial ProteinsBacterial ToxinsCalciumExotoxinsHemolysin ProteinsInterleukin-8leukocidin AB, Staphylococcus aureusLeukocidinsLukE protein, Staphylococcus aureusLukF protein, Staphylococcus aureusNF-kappa BPanton-Valentine leukocidinRecombinant ProteinsRNA, MessengerVirulence Factors

Identifiers

PMID24586678
PMCPMC3930693
OpenAlexW1988364622

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.